Urinary bladder dose-response relationships for patient-reported genitourinary morbidity domains following prostate cancer radiotherapy Journal Article
| Authors: | Thor, M.; Olsson, C.; Oh, J. H.; Petersen, S. E.; Alsadius, D.; Bentzen, L.; Pettersson, N.; Muren, L. P.; Hoyer, M.; Steineck, G.; Deasy, J. O. |
| Article Title: | Urinary bladder dose-response relationships for patient-reported genitourinary morbidity domains following prostate cancer radiotherapy |
| Abstract: | Background and purpose: Radiotherapy (RT) induced genitourinary (GU) morbidity is typically assessed by physicians as single symptoms or aggregated scores including symptoms from various domains. Here we apply a method to group patient-reported GU symptoms after RT for localized prostate cancer based on their interplay, and study how these relate to urinary bladder dose. Materials and methods: Data were taken from two Scandinavian studies (N = 207/276) including men treated with external-beam RT (EBRT) to 78/70 Gy (2 Gy/fraction; median time-to-follow-up: 3.6-6.4 y). Within and across cohorts, bladder dose-volume parameters were tested as predictors for GU symptom domains identified from two study-specific questionnaires (35 questions on frequency, incontinence, obstruction, pain, urgency, and sensory symptoms) using univariate and multivariate logistic regression analysis (MVA) with 10-fold cross-validation. Performance was evaluated using Area Under the Receiver Operating Characteristic Curve (A(z)). Results: For the identified Incontinence (2-5 symptoms), Obstruction (3-5 symptoms), and Urgency (2-7 symptoms) domains, MVA demonstrated that bladder doses close to the prescription doses were the strongest predictors for Obstruction (A(z): 0.53-0.57) and Urgency (A(z): 0.60). For Obstruction, performance increased for the across cohort analysis (A(z): 0.61-0.64). Conclusions: Our identified patient-reported GU symptom domains suggest that high urinary bladder doses, and increased focus on both obstruction and urgency is likely to further add to the understanding of GU tract RT responses. Published by Elsevier Ireland Ltd. |
| Keywords: | radiotherapy; survivors; prostate cancer; toxicity; outcomes; validation; bladder; radiation-therapy; composite; patient-reported outcome; dose-response; scoring-system |
| Journal Title: | Radiotherapy and Oncology |
| Volume: | 119 |
| Issue: | 1 |
| ISSN: | 0167-8140 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2016-04-01 |
| Start Page: | 117 |
| End Page: | 122 |
| Language: | English |
| ACCESSION: | WOS:000375822700021 |
| DOI: | 10.1016/j.radonc.2016.01.013 |
| PROVIDER: | wos |
| PUBMED: | 26879287 |
| PMCID: | PMC5512537 |
| Notes: | Article -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work